Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-17 5:04 pm Purchase | 2023-02-09 | 13G | aTyr Pharma, Inc. ATYR | Stonepine Capital Management, LLC | 4,569,433 8.900% | 4,569,433 (New Position) | Filing History |
| 2023-02-13 10:58 am Sale | 2022-12-31 | 13G | Exagen Inc. XGN | Stonepine Capital Management, LLC | 854,042 5.200% | -4,525 (-0.53%) | Filing History |
| 2023-02-13 10:57 am Purchase | 2022-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS | Stonepine Capital Management, LLC | 11,195,189 8.200% | 4,704,090 (+72.47%) | Filing History |
| 2023-02-13 10:57 am Purchase | 2022-12-31 | 13G | UroGen Pharma Ltd. URGN | Stonepine Capital Management, LLC | 1,304,947 5.700% | 108,039 (+9.03%) | Filing History |
| 2023-02-13 10:56 am Purchase | 2022-12-31 | 13G | Conformis, Inc. CFMS | Stonepine Capital Management, LLC | 748,194 9.900% | 748,194 (New Position) | Filing History |
| 2023-02-13 10:55 am Sale | 2022-12-31 | 13G | ADMA Biologics, Inc. ADMA | Stonepine Capital Management, LLC | 6,940,000 3.100% | -2,971,577 (-29.98%) | Filing History |
| 2023-02-13 10:35 am Purchase | 2022-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Stonepine Capital Management, LLC | 4,351,088 9.000% | 1,695,959 (+63.87%) | Filing History |
| 2023-02-13 10:29 am Purchase | 2022-12-31 | 13G | Rezolute, Inc. RZLT | Stonepine Capital Management, LLC | 3,021,504 8.200% | 2,213,099 (+273.76%) | Filing History |
| 2023-02-13 10:28 am Sale | 2022-12-31 | 13G | Ovid Therapeutics Inc. OVID | Stonepine Capital Management, LLC | 0 0.000% | -4,006,185 (Position Closed) | Filing History |
| 2023-02-13 10:27 am Sale | 2022-12-31 | 13G | CTI BioPharma Corp. CTIC | Stonepine Capital Management, LLC | 5,664,100 4.500% | -4,090,835 (-41.94%) | Filing History |
| 2023-02-13 10:24 am Purchase | 2022-12-31 | 13G | Amryt Pharma plc AMYT | Stonepine Capital Management, LLC | 31,666,195 9.900% | 1,317,320 (+4.34%) | Filing History |
| 2023-01-18 6:03 pm Purchase | 2023-01-09 | 13G | Third Harmonic Bio, Inc. THRD | Stonepine Capital Management, LLC | 2,152,968 5.300% | 2,152,968 (New Position) | Filing History |
| 2022-12-02 11:15 am Purchase | 2022-11-22 | 13G | UroGen Pharma Ltd. URGN | Stonepine Capital Management, LLC | 1,196,908 5.200% | 1,196,908 (New Position) | Filing History |
| 2022-02-14 08:21 am Sale | 2021-12-31 | 13G | ADMA Biologics, Inc. ADMA | Stonepine Capital Management, LLC | 9,911,577 5.100% | -61,300 (-0.61%) | Filing History |
| 2022-02-11 7:47 pm Sale | 2021-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS | Stonepine Capital Management, LLC | 0 0.000% | -3,408,849 (Position Closed) | Filing History |
| 2022-02-11 7:26 pm Purchase | 2021-12-31 | 13G | Exagen Inc. XGN | Stonepine Capital Management, LLC | 858,567 5.300% | 25,030 (+3.00%) | Filing History |
| 2022-02-11 7:06 pm Purchase | 2021-12-31 | 13G | CTI BioPharma Corp. CTIC | Stonepine Capital Management, LLC | 9,754,935 9.990% | 1,606,515 (+19.72%) | Filing History |
| 2022-02-11 7:03 pm Purchase | 2021-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Stonepine Capital Management, LLC | 2,655,129 6.500% | 51,649 (+1.98%) | Filing History |
| 2022-02-11 6:45 pm Purchase | 2021-12-31 | 13G | Rezolute, Inc. RZLT | Stonepine Capital Management, LLC | 808,405 5.200% | 19,079 (+2.42%) | Filing History |
| 2022-02-11 6:24 pm Purchase | 2021-12-31 | 13G | Conformis, Inc. CFMS | Stonepine Capital Management, LLC | 590,753 7.900% | 224,278 (+61.20%) | Filing History |